Unlock instant, AI-driven research and patent intelligence for your innovation.
Pharmaceutical composition containing prasugrel
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and drug technology, applied in the field of medicine, can solve the problems of reducing patient compliance, rebound of cardiovascular events, etc., and achieve the effects of reducing bleeding rate, enhancing anticoagulant activity, and inhibiting platelet aggregation.
Active Publication Date: 2011-01-12
LUNAN PHARMA GROUP CORPORATION
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
If the drug induces an increased risk of bleeding, even if the bleeding is not severe, it will significantly reduce the patient's compliance. Reduced compliance or bleeding risk is important in antiplatelet agents, which may lead to rebound cardiovascular events
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0014] Embodiment 1 common tablet
[0015] Proanthocyanidins 200g
[0016] Prasugrel Maleate 10g
[0017] Microcrystalline Cellulose 250g
[0018] Lactose 40g
[0019] 10% starch slurry appropriate amount
[0020] Magnesium Stearate 4g
[0021] Preparation process: Weigh the prescribed amount of proanthocyanidins, prasugrel maleate, microcrystalline cellulose, and lactose and mix evenly. In addition, add an appropriate amount of 10% starch slurry to the mixed powder, mix evenly, make soft material, pass through a 18-mesh nylon sieve to make wet granules, and dry at about 60°C. The moisture content of the dry granules should be controlled below 1.5%. Sieve through a 20-mesh sieve, mix with magnesium stearate, and press into tablets.
Embodiment 2
[0022] Embodiment 2 common tablet
[0023] Catechin 50g
[0024] Prasugrel hydrochloride 5g
[0025] Starch 140g
[0026] Dextrin 50g
[0027] 50% ethanol appropriate amount
[0028] Magnesium Stearate 1g
[0029] Preparation process: Weigh the prescribed amount of catechin, prasugrel hydrochloride, starch, and dextrin and mix evenly. In addition, add an appropriate amount of 50% ethanol to the pre-mixed powder, mix evenly, make soft materials, pass through a 18-mesh nylon sieve to make wet granules, and dry at about 60°C. The moisture content of dry granules should be controlled below 1.5%. Sieve through a 20-mesh sieve, mix with magnesium stearate, and press into tablets.
[0038] Preparation process: Weigh epicatechin and prasugrel according to the prescription, use microcrystalline cellulose as filler, croscarmellose sodium and polyvinylpyrrolidone as disintegrants, 5% PVP 60% alcohol solution It is used as binder, and micronized silica gel is used as flow aid. It is granulated in one step in a fluidized bed, and then compressed into tablets.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention provides a pharmaceutical composition containing active procyanidins and prasugrel or the pharmacologically acceptable salt thereof. The procyanidins and the prasugrel are used in a combined manner, a more effective method for curing thrombotic diseases is found, after trail for many times, the prasugrel and the procyanidins (an extract of traditional Chinese medicine) are creativelyand effectively combined together, the effect of applying the procyanidins to inhibit the thrombosis in a combined manner is discovered unexpected in the process of applying the prasugrel to cure thethrombotic diseases, and not only the anticoagulant effect of the prasugrel is free from the influence of the procyanidins, but also a good effect is achieved in the aspect of reducing the adverse reaction of bleeding after the use of the prasugrel and the procyanidins in a combined manner, therefore, the risk of bleeding is greatly reduced when the advantages of good anticoagulant activity and fast effect of the prasugrel during the antiplatelet aggregation are fully exerted, the risk of bleeding of the prasugrel during the antiplatelet aggregation is effectively reduced and the adverse reaction of the prasugrel is greatly reduced.
Description
technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition comprising proanthocyanidin and prasugrel or a pharmacologically acceptable salt thereof as active ingredients. Background technique [0002] Anthocyanin (anthocyanin) belongs to flavonoids in phenolic compounds, is a kind of water-soluble pigment, and is a kind of main coloring substance widely present in plants, which can change color with the acidity and alkalinity of cell fluid (cell fluid If it is acidic, it will be reddish, and if the cell fluid is alkaline, it will be blue), and it is mostly found in plants such as grapes, apples, sorghum and cherries, among which grapes (seeds and skins) are the most abundant. Anthocyanin is one of the main pigments that constitute the color of petals and fruits. It is composed of different amounts of catechin or epicatechin. Free anthocyanins are extremely rare under natural conditions. Proanthoc...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More 
